Free morning briefing · 07:30 weekdays
The RNS that moves prices, in your inbox before the open.
AI-ranked movers and high-impact RNS across the FTSE 100, 250, SmallCap and AIM — one short email, every market day.
Get the briefing
HVO

hVIVO plc

HVOLSEUnited KingdomHealthcareDiagnostics & ResearchAIM

hVIVO plc operates as a full-service early specialist contract research organisation in the United Kingdom, Europe, and North America. It provides end-to-end early clinical development services to the biopharmaceutical industry, including phase I capabilities and world leading human challenge trial…more

HVO

hVIVO plc

hVIVO plc operates as a full-service early specialist contract research organisation in the United Kingdom, Europe, and North America. It provides end-to-end early clinical development services to the biopharmaceutical industry, including phase I capabilities and world leading human challenge trial…more

Analyst consensus: Buy

As of 12 Aug 2026, 8 analysts rate hVIVO plc a Buy, with 75% buy ratings and a mean price target of 17p (range 10p–29p), +151% vs the current price.

Strong buy: 0Buy: 6Hold: 2Sell: 0Strong sell: 0

Full analyst history →

More Healthcare companies